Bill > HB430

This bill mandates that group health plans and health insurance issuers offering group or individual coverage must provide benefits for clinical genetic testing for inherited gene mutations in individuals with a personal or family history of cancer, if recommended by a healthcare professional, and for evidence-based cancer imaging for those at increased risk, as outlined by the National Comprehensive Cancer Network (NCCN) clinical practice guidelines. Importantly, these plans and issuers are prohibited from imposing any cost-sharing requirements, such as deductibles, coinsurance, or copayments, for these specific genetic testing and imaging services, ensuring no out-of-pocket expenses for patients. The bill also includes provisions to bring forward Section 25-15-9 of the Mississippi Code of 1972, which pertains to the formulation of the State Employees Life and Health Insurance Plan, ensuring its continued relevance and application.

Business and Industry

https://billstatus.ls.state.ms.us/2026/pdf/history/HB/HB0430.xml